2o61 Citations

An atomic model of the interferon-beta enhanceosome.

Cell 129 1111-23 (2007)
Cited: 394 times
EuropePMC logo PMID: 17574024

Abstract

Transcriptional activation of the interferon-beta (IFN-beta) gene requires assembly of an enhanceosome containing ATF-2/c-Jun, IRF-3/IRF-7, and NFkappaB. These factors bind cooperatively to the IFN-beta enhancer and recruit coactivators and chromatin-remodeling proteins to the IFN-beta promoter. We describe here a crystal structure of the DNA-binding domains of IRF-3, IRF-7, and NFkappaB, bound to one half of the enhancer, and use a previously described structure of the remaining half to assemble a complete picture of enhanceosome architecture in the vicinity of the DNA. Association of eight proteins with the enhancer creates a continuous surface for recognizing a composite DNA-binding element. Paucity of local protein-protein contacts suggests that cooperative occupancy of the enhancer comes from both binding-induced changes in DNA conformation and interactions with additional components such as CBP. Contacts with virtually every nucleotide pair account for the evolutionary invariance of the enhancer sequence.

Reviews - 2o61 mentioned but not cited (3)

  1. Absence of a simple code: how transcription factors read the genome. Slattery M, Zhou T, Yang L, Dantas Machado AC, Gordân R, Rohs R. Trends Biochem Sci 39 381-399 (2014)
  2. Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease. Antonczyk A, Krist B, Sajek M, Michalska A, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HAR. Front Immunol 10 1176 (2019)
  3. Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes. Padariya M, Sznarkowska A, Kote S, Gómez-Herranz M, Mikac S, Pilch M, Alfaro J, Fahraeus R, Hupp T, Kalathiya U. Biomolecules 11 622 (2021)

Articles - 2o61 mentioned but not cited (27)

  1. An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells. Vinogradova EV, Zhang X, Remillard D, Lazar DC, Suciu RM, Wang Y, Bianco G, Yamashita Y, Crowley VM, Schafroth MA, Yokoyama M, Konrad DB, Lum KM, Simon GM, Kemper EK, Lazear MR, Yin S, Blewett MM, Dix MM, Nguyen N, Shokhirev MN, Chin EN, Lairson LL, Melillo B, Schreiber SL, Forli S, Teijaro JR, Cravatt BF. Cell 182 1009-1026.e29 (2020)
  2. The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation. Carpi S, Scoditti E, Massaro M, Polini B, Manera C, Digiacomo M, Esposito Salsano J, Poli G, Tuccinardi T, Doccini S, Santorelli FM, Carluccio MA, Macchia M, Wabitsch M, De Caterina R, Nieri P. Nutrients 11 E2855 (2019)
  3. The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. Acuner Ozbabacan SE, Gursoy A, Nussinov R, Keskin O. PLoS Comput Biol 10 e1003470 (2014)
  4. A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcription. Chinnaswamy S, Chatterjee S, Boopathi R, Mukherjee S, Bhattacharjee S, Kundu TK. PLoS One 8 e75495 (2013)
  5. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. Mosharaf MP, Reza MS, Kibria MK, Ahmed FF, Kabir MH, Hasan S, Mollah MNH. Sci Rep 12 4279 (2022)
  6. Predicting target DNA sequences of DNA-binding proteins based on unbound structures. Chen CY, Chien TY, Lin CK, Lin CW, Weng YZ, Chang DT. PLoS One 7 e30446 (2012)
  7. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. Ahmed FF, Reza MS, Sarker MS, Islam MS, Mosharaf MP, Hasan S, Mollah MNH. PLoS One 17 e0266124 (2022)
  8. Single-residue posttranslational modification sites at the N-terminus, C-terminus or in-between: To be or not to be exposed for enzyme access. Sirota FL, Maurer-Stroh S, Eisenhaber B, Eisenhaber F. Proteomics 15 2525-2546 (2015)
  9. Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF-κB-regulated gene expression and sensitization of tumor cells to chemotherapeutic agents. Gupta SC, Kannappan R, Kim J, Rahman GM, Francis SK, Raveendran R, Nair MS, Das J, Aggarwal BB. Mol Pharmacol 80 769-781 (2011)
  10. Synthesis and Spectroscopic Analysis of Piperine- and Piperlongumine-Inspired Natural Product Scaffolds and Their Molecular Docking with IL-1β and NF-κB Proteins. Zazeri G, Povinelli APR, Le Duff CS, Tang B, Cornelio ML, Jones AM. Molecules 25 E2841 (2020)
  11. The role of response elements organization in transcription factor selectivity: the IFN-β enhanceosome example. Pan Y, Nussinov R. PLoS Comput Biol 7 e1002077 (2011)
  12. A mechanism of global shape-dependent recognition and phosphorylation of filamin by protein kinase A. Ithychanda SS, Fang X, Mohan ML, Zhu L, Tirupula KC, Naga Prasad SV, Wang YX, Karnik SS, Qin J. J Biol Chem 290 8527-8538 (2015)
  13. Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA binding. De Ioannes P, Escalante CR, Aggarwal AK. Nucleic Acids Res 39 7300-7307 (2011)
  14. Disseminated Talaromyces marneffei Infection in a Non-HIV Infant With a Homozygous Private Variant of RELB. Ding X, Huang H, Zhong L, Chen M, Peng F, Zhang B, Cui X, Yang XA. Front Cell Infect Microbiol 11 605589 (2021)
  15. Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking. Guo S, Wu J, Zhou W, Liu X, Zhang J, Jia S, Meng Z, Liu S, Ni M, Liu Y. BMC Complement Med Ther 20 66 (2020)
  16. Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase. Batool S, Nawaz MS, Greig NH, Rehan M, Kamal MA. Antiinflamm Antiallergy Agents Med Chem 12 129-135 (2013)
  17. Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration. Liu J, Liu S, Yu Z, Qiu X, Jiang R, Li W. J Transl Med 20 604 (2022)
  18. Single-molecule conformational dynamics of a transcription factor reveals a continuum of binding modes controlling association and dissociation. Chen W, Lu W, Wolynes PG, Komives EA. Nucleic Acids Res 49 11211-11223 (2021)
  19. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing. Islam MA, Kibria MK, Hossen MB, Reza MS, Tasmia SA, Tuly KF, Mosharof MP, Kabir SR, Kabir MH, Mollah MNH. Sci Rep 13 4685 (2023)
  20. Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt/ERK signaling pathways. Pan B, Xia Y, Gao Z, Zhao G, Wang L, Fang S, Liu L, Yan S. Chin Med 17 36 (2022)
  21. Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease. Oh KK, Choi YR, Gupta H, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, Kim DJ, Suk KT. Curr Issues Mol Biol 44 3253-3266 (2022)
  22. In vitro and in silico analysis of 'Taikong blue' lavender essential oil in LPS-induced HaCaT cells and RAW264.7 murine macrophages. Wei M, Liu F, Raka RN, Xiang J, Xiao J, Han T, Guo F, Yang S, Wu H. BMC Complement Med Ther 22 324 (2022)
  23. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  24. Curcumin's mechanism of action against ischemic stroke: A network pharmacology and molecular dynamics study. Wang Y, Zu G, Yu Y, Tang J, Han T, Zhang C. PLoS One 18 e0280112 (2023)
  25. PPARβ/δ-Interfering Peptide Enhanced Mesenchymal Stromal Cell Immunoregulatory Properties. Tejedor G, Boisguerin P, Vivès É, Jorgensen C, Guicheux J, Vinatier C, Gondeau C, Djouad F. Stem Cells Int 2022 5494749 (2022)
  26. Revealing Potential Bioactive Compounds and Mechanisms of Lithospermum erythrorhizon against COVID-19 via Network Pharmacology Study. Oh KK, Adnan M. Curr Issues Mol Biol 44 1788-1809 (2022)
  27. Rhoifolin Alleviates Alcoholic Liver Disease In Vivo and In Vitro via Inhibition of the TLR4/NF-κB Signaling Pathway. Mai B, Han L, Zhong J, Shu J, Cao Z, Fang J, Zhang X, Gao Z, Xiao F. Front Pharmacol 13 878898 (2022)


Reviews citing this publication (99)

  1. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. Randall RE, Goodbourn S. J Gen Virol 89 1-47 (2008)
  2. Transcription factors: from enhancer binding to developmental control. Spitz F, Furlong EE. Nat Rev Genet 13 613-626 (2012)
  3. Interferons at age 50: past, current and future impact on biomedicine. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. Nat Rev Drug Discov 6 975-990 (2007)
  4. Origins of specificity in protein-DNA recognition. Rohs R, Jin X, West SM, Joshi R, Honig B, Mann RS. Annu Rev Biochem 79 233-269 (2010)
  5. Epigenetic reprogramming and induced pluripotency. Hochedlinger K, Plath K. Development 136 509-523 (2009)
  6. IRF7: activation, regulation, modification and function. Ning S, Pagano JS, Barber GN. Genes Immun 12 399-414 (2011)
  7. Enhancers: five essential questions. Pennacchio LA, Bickmore W, Dean A, Nobrega MA, Bejerano G. Nat Rev Genet 14 288-295 (2013)
  8. The origin of protein interactions and allostery in colocalization. Kuriyan J, Eisenberg D. Nature 450 983-990 (2007)
  9. Selective transcription in response to an inflammatory stimulus. Smale ST. Cell 140 833-844 (2010)
  10. Hierarchies of NF-κB target-gene regulation. Smale ST. Nat Immunol 12 689-694 (2011)
  11. The enhanceosome. Panne D. Curr Opin Struct Biol 18 236-242 (2008)
  12. Choose your partners: dimerization in eukaryotic transcription factors. Amoutzias GD, Robertson DL, Van de Peer Y, Oliver SG. Trends Biochem Sci 33 220-229 (2008)
  13. Disentangling the many layers of eukaryotic transcriptional regulation. Lelli KM, Slattery M, Mann RS. Annu Rev Genet 46 43-68 (2012)
  14. Interferons and their stimulated genes in the tumor microenvironment. Cheon H, Borden EC, Stark GR. Semin Oncol 41 156-173 (2014)
  15. In pursuit of design principles of regulatory sequences. Levo M, Segal E. Nat Rev Genet 15 453-468 (2014)
  16. NF-κB regulation: lessons from structures. Ghosh G, Wang VY, Huang DB, Fusco A. Immunol Rev 246 36-58 (2012)
  17. Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. Zhao GN, Jiang DS, Li H. Biochim Biophys Acta 1852 365-378 (2015)
  18. Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Elgar G, Vavouri T. Trends Genet 24 344-352 (2008)
  19. Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus. Yoo D, Song C, Sun Y, Du Y, Kim O, Liu HC. Virus Res 154 48-60 (2010)
  20. Induction of type I interferons by bacteria. Monroe KM, McWhirter SM, Vance RE. Cell Microbiol 12 881-890 (2010)
  21. Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Pfaller CK, Li Z, George CX, Samuel CE. Curr Opin Immunol 23 573-582 (2011)
  22. No Love Lost Between Viruses and Interferons. Fensterl V, Chattopadhyay S, Sen GC. Annu Rev Virol 2 549-572 (2015)
  23. Structural perspective of cooperative transcription factor binding. Morgunova E, Taipale J. Curr Opin Struct Biol 47 1-8 (2017)
  24. HMGA proteins as modulators of chromatin structure during transcriptional activation. Ozturk N, Singh I, Mehta A, Braun T, Barreto G. Front Cell Dev Biol 2 5 (2014)
  25. Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation. Platanitis E, Decker T. Front Immunol 9 2542 (2018)
  26. Interferon-regulatory factors determine macrophage phenotype polarization. Günthner R, Anders HJ. Mediators Inflamm 2013 731023 (2013)
  27. Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity. Smith JA. Front Immunol 9 422 (2018)
  28. Global virus outbreaks: Interferons as 1st responders. Wang BX, Fish EN. Semin Immunol 43 101300 (2019)
  29. The role of differential expression of human interferon--a genes in antiviral immunity. Génin P, Vaccaro A, Civas A. Cytokine Growth Factor Rev 20 283-295 (2009)
  30. Low-Affinity Binding Sites and the Transcription Factor Specificity Paradox in Eukaryotes. Kribelbauer JF, Rastogi C, Bussemaker HJ, Mann RS. Annu Rev Cell Dev Biol 35 357-379 (2019)
  31. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development. Sumter TF, Xian L, Huso T, Koo M, Chang YT, Almasri TN, Chia L, Inglis C, Reid D, Resar LM. Curr Mol Med 16 353-393 (2016)
  32. A new paradigm: innate immune sensing of viruses via the unfolded protein response. Smith JA. Front Microbiol 5 222 (2014)
  33. Comparative genomics of gene regulation-conservation and divergence of cis-regulatory information. Meireles-Filho AC, Stark A. Curr Opin Genet Dev 19 565-570 (2009)
  34. Recent molecular insights into rickettsial pathogenesis and immunity. Sahni SK, Narra HP, Sahni A, Walker DH. Future Microbiol 8 1265-1288 (2013)
  35. A structural guide to proteins of the NF-kappaB signaling module. Huxford T, Ghosh G. Cold Spring Harb Perspect Biol 1 a000075 (2009)
  36. Cytosolic surveillance and antiviral immunity. Rathinam VA, Fitzgerald KA. Curr Opin Virol 1 455-462 (2011)
  37. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Zinzula L, Tramontano E. Antiviral Res 100 615-635 (2013)
  38. Structural insights into interferon regulatory factor activation. Chen W, Royer WE. Cell Signal 22 883-887 (2010)
  39. Cytoplasmic nucleic acid sensors in antiviral immunity. Ranjan P, Bowzard JB, Schwerzmann JW, Jeisy-Scott V, Fujita T, Sambhara S. Trends Mol Med 15 359-368 (2009)
  40. The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons. Dussurget O, Bierne H, Cossart P. Front Cell Infect Microbiol 4 50 (2014)
  41. Innate antiviral immune signaling, viral evasion and modulation by HIV-1. Rustagi A, Gale M. J Mol Biol 426 1161-1177 (2014)
  42. Evolution of transcriptional control in mammals. Wilson MD, Odom DT. Curr Opin Genet Dev 19 579-585 (2009)
  43. The chromatin landscape and transcription factors in T cell programming. Rothenberg EV. Trends Immunol 35 195-204 (2014)
  44. Enhancer grammar in development, evolution, and disease: dependencies and interplay. Jindal GA, Farley EK. Dev Cell 56 575-587 (2021)
  45. The intricate interplay between RNA viruses and NF-κB. Schmitz ML, Kracht M, Saul VV. Biochim Biophys Acta 1843 2754-2764 (2014)
  46. Activation and regulation of interferon-β in immune responses. Sin WX, Li P, Yeong JP, Chin KC. Immunol Res 53 25-40 (2012)
  47. Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy. Garland KM, Sheehy TL, Wilson JT. Chem Rev 122 5977-6039 (2022)
  48. Genome reading by the NF-κB transcription factors. Mulero MC, Wang VY, Huxford T, Ghosh G. Nucleic Acids Res 47 9967-9989 (2019)
  49. Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS). Ebstein F, Poli Harlowe MC, Studencka-Turski M, Krüger E. Front Immunol 10 2756 (2019)
  50. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer. Provance OK, Lewis-Wambi J. Breast Cancer Res 21 59 (2019)
  51. Dissecting the regulatory switches of development: lessons from enhancer evolution in Drosophila. Borok MJ, Tran DA, Ho MC, Drewell RA. Development 137 5-13 (2010)
  52. Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming. Malik V, Zimmer D, Jauch R. Cell Mol Life Sci 75 1587-1612 (2018)
  53. Interferon Regulatory Factor 9 Structure and Regulation. Paul A, Tang TH, Ng SK. Front Immunol 9 1831 (2018)
  54. Transcriptional Activation of Inflammatory Genes: Mechanistic Insight into Selectivity and Diversity. Ahmed AU, Williams BR, Hannigan GE. Biomolecules 5 3087-3111 (2015)
  55. Porcine Epidemic Diarrhea Virus and the Host Innate Immune Response. Li S, Yang J, Zhu Z, Zheng H. Pathogens 9 E367 (2020)
  56. The high mobility group A1 molecular switch: turning on cancer - can we turn it off? Huso TH, Resar LM. Expert Opin Ther Targets 18 541-553 (2014)
  57. Induction and control of the type I interferon pathway by Bluetongue virus. Vitour D, Doceul V, Ruscanu S, Chauveau E, Schwartz-Cornil I, Zientara S. Virus Res 182 59-70 (2014)
  58. Functional anatomy of distant-acting mammalian enhancers. Dickel DE, Visel A, Pennacchio LA. Philos Trans R Soc Lond B Biol Sci 368 20120359 (2013)
  59. The viral innate immune antagonism and an alternative vaccine design for PRRS virus. Ke H, Yoo D. Vet Microbiol 209 75-89 (2017)
  60. When needles look like hay: how to find tissue-specific enhancers in model organism genomes. Haeussler M, Joly JS. Dev Biol 350 239-254 (2011)
  61. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes. Wittling MC, Cahalan SR, Levenson EA, Rabin RL. Front Immunol 11 605673 (2020)
  62. The regulatory action of the myxobacterial CarD/CarG complex: a bacterial enhanceosome? Elías-Arnanz M, Padmanabhan S, Murillo FJ. FEMS Microbiol Rev 34 764-778 (2010)
  63. Deciphering the multi-scale, quantitative cis-regulatory code. Kim S, Wysocka J. Mol Cell 83 373-392 (2023)
  64. Innate immune evasion strategies of SARS-CoV-2. Minkoff JM, tenOever B. Nat Rev Microbiol 21 178-194 (2023)
  65. Multiple layers of complexity in cis-regulatory regions of developmental genes. Frankel N. Dev Dyn 241 1857-1866 (2012)
  66. Merging Established Mechanisms with New Insights: Condensates, Hubs, and the Regulation of RNA Polymerase II Transcription. Palacio M, Taatjes DJ. J Mol Biol 434 167216 (2022)
  67. Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent IFNB1 Expression. Schwanke H, Stempel M, Brinkmann MM. Viruses 12 E733 (2020)
  68. A tale of chromatin and transcription in 100 structures. Cramer P. Cell 159 985-994 (2014)
  69. Deciphering the genome's regulatory code: the many languages of DNA. Rister J, Desplan C. Bioessays 32 381-384 (2010)
  70. Expanding the specificity of DNA targeting by harnessing cooperative assembly. Moretti R, Ansari AZ. Biochimie 90 1015-1025 (2008)
  71. Antiviral interferon response at single-cell resolution. Talemi SR, Höfer T. Immunol Rev 285 72-80 (2018)
  72. The animal in the genome: comparative genomics and evolution. Copley RR. Philos Trans R Soc Lond B Biol Sci 363 1453-1461 (2008)
  73. Transcriptional enhancers and their communication with gene promoters. Ray-Jones H, Spivakov M. Cell Mol Life Sci 78 6453-6485 (2021)
  74. Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention. Trilling M, Le VT, Hengel H. Future Microbiol 7 1269-1282 (2012)
  75. Transcriptional and epigenetic regulations of embryonic stem cells. Ng JH, Heng JC, Loh YH, Ng HH. Mutat Res 647 52-58 (2008)
  76. Emerging Roles of Protein Deamidation in Innate Immune Signaling. Zhao J, Li J, Xu S, Feng P. J Virol 90 4262-4268 (2016)
  77. Nuclear magnetic resonance analysis of protein-DNA interactions. Campagne S, Gervais V, Milon A. J R Soc Interface 8 1065-1078 (2011)
  78. Roles of GSK-3 and β-Catenin in Antiviral Innate Immune Sensing of Nucleic Acids. Marineau A, Khan KA, Servant MJ. Cells 9 E897 (2020)
  79. Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease. Fox LE, Locke MC, Lenschow DJ. Front Immunol 11 606874 (2020)
  80. Evolution of Regulated Transcription. Bylino OV, Ibragimov AN, Shidlovskii YV. Cells 9 E1675 (2020)
  81. Motif co-regulation and co-operativity are common mechanisms in transcriptional, post-transcriptional and post-translational regulation. Van Roey K, Davey NE. Cell Commun Signal 13 45 (2015)
  82. Sequence and chromatin determinants of transcription factor binding and the establishment of cell type-specific binding patterns. Srivastava D, Mahony S. Biochim Biophys Acta Gene Regul Mech 1863 194443 (2020)
  83. Stimulus-specific responses in innate immunity: Multilayered regulatory circuits. Luecke S, Sheu KM, Hoffmann A. Immunity 54 1915-1932 (2021)
  84. How structural biology transformed studies of transcription regulation. Wolberger C. J Biol Chem 296 100741 (2021)
  85. Runx proteins and transcriptional mechanisms that govern memory CD8 T cell development. Pipkin ME. Immunol Rev 300 100-124 (2021)
  86. The Causes and Consequences of Spatial Organization of the Genome in Regulation of Gene Expression. Agelopoulos M, Foutadakis S, Thanos D. Front Immunol 12 682397 (2021)
  87. Bacterial programming of host responses: coordination between type I interferon and cell death. Dhariwala MO, Anderson DM. Front Microbiol 5 545 (2014)
  88. Genomics and the immune system. Pipkin ME, Monticelli S. Immunology 124 23-32 (2008)
  89. Motif grammar: The basis of the language of gene expression. Nagy G, Nagy L. Comput Struct Biotechnol J 18 2026-2032 (2020)
  90. Transcriptional enhancers at 40: evolution of a viral DNA element to nuclear architectural structures. Nair SJ, Suter T, Wang S, Yang L, Yang F, Rosenfeld MG. Trends Genet 38 1019-1047 (2022)
  91. Modulation of Innate Antiviral Immune Response by Porcine Enteric Coronavirus. Zhang K, Lin S, Li J, Deng S, Zhang J, Wang S. Front Microbiol 13 845137 (2022)
  92. Post-translational Control of Innate Immune Signaling Pathways by Herpesviruses. Carriere J, Rao Y, Liu Q, Lin X, Zhao J, Feng P. Front Microbiol 10 2647 (2019)
  93. Typical Enhancers, Super-Enhancers, and Cancers. Koutsi MA, Pouliou M, Champezou L, Vatsellas G, Giannopoulou AI, Piperi C, Agelopoulos M. Cancers (Basel) 14 4375 (2022)
  94. Hold out the genome: a roadmap to solving the cis-regulatory code. de Boer CG, Taipale J. Nature 625 41-50 (2024)
  95. Surgical Strikes on Host Defenses: Role of the Viral Protease Activity in Innate Immune Antagonism. Chin CV, Saeed M. Pathogens 11 522 (2022)
  96. Viral recognition and the antiviral interferon response. Dalskov L, Gad HH, Hartmann R. EMBO J 42 e112907 (2023)
  97. Measles Virus-Induced Host Immunity and Mechanisms of Viral Evasion. Amurri L, Reynard O, Gerlier D, Horvat B, Iampietro M. Viruses 14 2641 (2022)
  98. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness? Sacchi A, Giannessi F, Sabatini A, Percario ZA, Affabris E. Int J Mol Sci 24 9353 (2023)
  99. Strand asymmetries across genomic processes. Moeckel C, Zaravinos A, Georgakopoulos-Soares I. Comput Struct Biotechnol J 21 2036-2047 (2023)

Articles citing this publication (265)

  1. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, Loh YH, Yeo HC, Yeo ZX, Narang V, Govindarajan KR, Leong B, Shahab A, Ruan Y, Bourque G, Sung WK, Clarke ND, Wei CL, Ng HH. Cell 133 1106-1117 (2008)
  2. Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains. Boija A, Klein IA, Sabari BR, Dall'Agnese A, Coffey EL, Zamudio AV, Li CH, Shrinivas K, Manteiga JC, Hannett NM, Abraham BJ, Afeyan LK, Guo YE, Rimel JK, Fant CB, Schuijers J, Lee TI, Taatjes DJ, Young RA. Cell 175 1842-1855.e16 (2018)
  3. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Pertel T, Hausmann S, Morger D, Züger S, Guerra J, Lascano J, Reinhard C, Santoni FA, Uchil PD, Chatel L, Bisiaux A, Albert ML, Strambio-De-Castillia C, Mothes W, Pizzato M, Grütter MG, Luban J. Nature 472 361-365 (2011)
  4. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Melnikov A, Murugan A, Zhang X, Tesileanu T, Wang L, Rogov P, Feizi S, Gnirke A, Callan CG, Kinney JB, Kellis M, Lander ES, Mikkelsen TS. Nat Biotechnol 30 271-277 (2012)
  5. Transcriptional enhancers in animal development and evolution. Levine M. Curr Biol 20 R754-63 (2010)
  6. DNA-dependent formation of transcription factor pairs alters their binding specificity. Jolma A, Yin Y, Nitta KR, Dave K, Popov A, Taipale M, Enge M, Kivioja T, Morgunova E, Taipale J. Nature 527 384-388 (2015)
  7. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Li S, Wang L, Berman M, Kong YY, Dorf ME. Immunity 35 426-440 (2011)
  8. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. Soulat D, Bürckstümmer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. EMBO J 27 2135-2146 (2008)
  9. Sepsid even-skipped enhancers are functionally conserved in Drosophila despite lack of sequence conservation. Hare EE, Peterson BK, Iyer VN, Meier R, Eisen MB. PLoS Genet 4 e1000106 (2008)
  10. Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits. Ulirsch JC, Nandakumar SK, Wang L, Giani FC, Zhang X, Rogov P, Melnikov A, McDonel P, Do R, Mikkelsen TS, Sankaran VG. Cell 165 1530-1545 (2016)
  11. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Sharma S, DeOliveira RB, Kalantari P, Parroche P, Goutagny N, Jiang Z, Chan J, Bartholomeu DC, Lauw F, Hall JP, Barber GN, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Immunity 35 194-207 (2011)
  12. Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression. Apostolou E, Thanos D. Cell 134 85-96 (2008)
  13. Nucleosome-mediated cooperativity between transcription factors. Mirny LA. Proc Natl Acad Sci U S A 107 22534-22539 (2010)
  14. Human TRIM gene expression in response to interferons. Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S. PLoS One 4 e4894 (2009)
  15. Suboptimization of developmental enhancers. Farley EK, Olson KM, Zhang W, Brandt AJ, Rokhsar DS, Levine MS. Science 350 325-328 (2015)
  16. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Schmitz F, Heit A, Dreher S, Eisenächer K, Mages J, Haas T, Krug A, Janssen KP, Kirschning CJ, Wagner H. Eur J Immunol 38 2981-2992 (2008)
  17. Probing allostery through DNA. Kim S, Broströmer E, Xing D, Jin J, Chong S, Ge H, Wang S, Gu C, Yang L, Gao YQ, Su XD, Sun Y, Xie XS. Science 339 816-819 (2013)
  18. Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. Lam E, Stein S, Falck-Pedersen E. J Virol 88 974-981 (2014)
  19. The DNA damage response induces IFN. Brzostek-Racine S, Gordon C, Van Scoy S, Reich NC. J Immunol 187 5336-5345 (2011)
  20. Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. del Fresno C, Soulat D, Roth S, Blazek K, Udalova I, Sancho D, Ruland J, Ardavín C. Immunity 38 1176-1186 (2013)
  21. Global reference mapping of human transcription factor footprints. Vierstra J, Lazar J, Sandstrom R, Halow J, Lee K, Bates D, Diegel M, Dunn D, Neri F, Haugen E, Rynes E, Reynolds A, Nelson J, Johnson A, Frerker M, Buckley M, Kaul R, Meuleman W, Stamatoyannopoulos JA. Nature 583 729-736 (2020)
  22. Suppression of type I interferon production by porcine epidemic diarrhea virus and degradation of CREB-binding protein by nsp1. Zhang Q, Shi K, Yoo D. Virology 489 252-268 (2016)
  23. Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant. Dalrymple NA, Cimica V, Mackow ER. mBio 6 e00553-15 (2015)
  24. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, Chen MS, Rioja I, Parravicini V, Prinjha RK, Chandwani R, MacDonald MR, Lee K, Rice CM, Tarakhovsky A. J Exp Med 209 661-669 (2012)
  25. Immediate mediators of the inflammatory response are poised for gene activation through RNA polymerase II stalling. Adelman K, Kennedy MA, Nechaev S, Gilchrist DA, Muse GW, Chinenov Y, Rogatsky I. Proc Natl Acad Sci U S A 106 18207-18212 (2009)
  26. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. Daffis S, Suthar MS, Szretter KJ, Gale M, Diamond MS. PLoS Pathog 5 e1000607 (2009)
  27. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Litvak V, Ratushny AV, Lampano AE, Schmitz F, Huang AC, Raman A, Rust AG, Bergthaler A, Aitchison JD, Aderem A. Nature 490 421-425 (2012)
  28. A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating Inflammation. Tong AJ, Liu X, Thomas BJ, Lissner MM, Baker MR, Senagolage MD, Allred AL, Barish GD, Smale ST. Cell 165 165-179 (2016)
  29. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Negishi H, Yanai H, Nakajima A, Koshiba R, Atarashi K, Matsuda A, Matsuki K, Miki S, Doi T, Aderem A, Nishio J, Smale ST, Honda K, Taniguchi T. Nat Immunol 13 659-666 (2012)
  30. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. Toth AM, Li Z, Cattaneo R, Samuel CE. J Biol Chem 284 29350-29356 (2009)
  31. Modulation of type I interferon induction by porcine reproductive and respiratory syndrome virus and degradation of CREB-binding protein by non-structural protein 1 in MARC-145 and HeLa cells. Kim O, Sun Y, Lai FW, Song C, Yoo D. Virology 402 315-326 (2010)
  32. XBP-1 couples endoplasmic reticulum stress to augmented IFN-beta induction via a cis-acting enhancer in macrophages. Zeng L, Liu YP, Sha H, Chen H, Qi L, Smith JA. J Immunol 185 2324-2330 (2010)
  33. NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. Wang J, Basagoudanavar SH, Wang X, Hopewell E, Albrecht R, García-Sastre A, Balachandran S, Beg AA. J Immunol 185 1720-1729 (2010)
  34. Allosteric modulation of DNA by small molecules. Chenoweth DM, Dervan PB. Proc Natl Acad Sci U S A 106 13175-13179 (2009)
  35. E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. Song G, Liu B, Li Z, Wu H, Wang P, Zhao K, Jiang G, Zhang L, Gao C. Nat Immunol 17 1342-1351 (2016)
  36. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, Schiffer CA, Fitzgerald KA, Lin K, Royer WE. Nat Struct Mol Biol 15 1213-1220 (2008)
  37. Functional dissection of the TBK1 molecular network. Goncalves A, Bürckstümmer T, Dixit E, Scheicher R, Górna MW, Karayel E, Sugar C, Stukalov A, Berg T, Kralovics R, Planyavsky M, Bennett KL, Colinge J, Superti-Furga G. PLoS One 6 e23971 (2011)
  38. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. Hou P, Meng S, Li M, Lin T, Chu S, Li Z, Zheng J, Gu Y, Bai J. J Exp Clin Cancer Res 40 52 (2021)
  39. Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins. Zhao B, Shu C, Gao X, Sankaran B, Du F, Shelton CL, Herr AB, Ji JY, Li P. Proc Natl Acad Sci U S A 113 E3403-12 (2016)
  40. Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Moreno R, Sobotzik JM, Schultz C, Schmitz ML. Nucleic Acids Res 38 6029-6044 (2010)
  41. A widespread role of the motif environment in transcription factor binding across diverse protein families. Dror I, Golan T, Levy C, Rohs R, Mandel-Gutfreund Y. Genome Res 25 1268-1280 (2015)
  42. Transcription factor redundancy ensures induction of the antiviral state. Schmid S, Mordstein M, Kochs G, García-Sastre A, Tenoever BR. J Biol Chem 285 42013-42022 (2010)
  43. Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. Jin J, Hu H, Li HS, Yu J, Xiao Y, Brittain GC, Zou Q, Cheng X, Mallette FA, Watowich SS, Sun SC. Immunity 40 342-354 (2014)
  44. Dual Role of p53 in Innate Antiviral Immunity. Rivas C, Aaronson SA, Munoz-Fontela C. Viruses 2 298-313 (2010)
  45. Characterization of fish IRF3 as an IFN-inducible protein reveals evolving regulation of IFN response in vertebrates. Sun F, Zhang YB, Liu TK, Gan L, Yu FF, Liu Y, Gui JF. J Immunol 185 7573-7582 (2010)
  46. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. Alff PJ, Sen N, Gorbunova E, Gavrilovskaya IN, Mackow ER. J Virol 82 9115-9122 (2008)
  47. The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. McAllister CS, Samuel CE. J Biol Chem 284 1644-1651 (2009)
  48. Gene regulatory mechanisms underpinning prostate cancer susceptibility. Whitington T, Gao P, Song W, Ross-Adams H, Lamb AD, Yang Y, Svezia I, Klevebring D, Mills IG, Karlsson R, Halim S, Dunning MJ, Egevad L, Warren AY, Neal DE, Grönberg H, Lindberg J, Wei GH, Wiklund F. Nat Genet 48 387-397 (2016)
  49. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, Mitchell T, Martin M. J Immunol 181 6797-6802 (2008)
  50. Transcription factor dimerization activates the p300 acetyltransferase. Ortega E, Rengachari S, Ibrahim Z, Hoghoughi N, Gaucher J, Holehouse AS, Khochbin S, Panne D. Nature 562 538-544 (2018)
  51. ATF3 Is a Key Regulator of Macrophage IFN Responses. Labzin LI, Schmidt SV, Masters SL, Beyer M, Krebs W, Klee K, Stahl R, Lütjohann D, Schultze JL, Latz E, De Nardo D. J Immunol 195 4446-4455 (2015)
  52. Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses. Sali TM, Pryke KM, Abraham J, Liu A, Archer I, Broeckel R, Staverosky JA, Smith JL, Al-Shammari A, Amsler L, Sheridan K, Nilsen A, Streblow DN, DeFilippis VR. PLoS Pathog 11 e1005324 (2015)
  53. Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. Gratz N, Siller M, Schaljo B, Pirzada ZA, Gattermeier I, Vojtek I, Kirschning CJ, Wagner H, Akira S, Charpentier E, Kovarik P. J Biol Chem 283 19879-19887 (2008)
  54. Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. McAllister CS, Toth AM, Zhang P, Devaux P, Cattaneo R, Samuel CE. J Virol 84 380-386 (2010)
  55. Structural and functional dissection of Mif2p, a conserved DNA-binding kinetochore protein. Cohen RL, Espelin CW, De Wulf P, Sorger PK, Harrison SC, Simons KT. Mol Biol Cell 19 4480-4491 (2008)
  56. Protein kinase PKR amplification of interferon β induction occurs through initiation factor eIF-2α-mediated translational control. McAllister CS, Taghavi N, Samuel CE. J Biol Chem 287 36384-36392 (2012)
  57. The Kinase IKKβ Regulates a STING- and NF-κB-Dependent Antiviral Response Pathway in Drosophila. Goto A, Okado K, Martins N, Cai H, Barbier V, Lamiable O, Troxler L, Santiago E, Kuhn L, Paik D, Silverman N, Holleufer A, Hartmann R, Liu J, Peng T, Hoffmann JA, Meignin C, Daeffler L, Imler JL. Immunity 49 225-234.e4 (2018)
  58. Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling. Zhang P, Samuel CE. J Biol Chem 283 34580-34587 (2008)
  59. Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Jin X, Kim SH, Jeon HM, Beck S, Sohn YW, Yin J, Kim JK, Lim YC, Lee JH, Kim SH, Kang SH, Pian X, Song MS, Park JB, Chae YS, Chung YG, Lee SH, Choi YJ, Nam DH, Choi YK, Kim H. Brain 135 1055-1069 (2012)
  60. Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus. Bartlett NW, Slater L, Glanville N, Haas JJ, Caramori G, Casolari P, Clarke DL, Message SD, Aniscenko J, Kebadze T, Zhu J, Mallia P, Mizgerd JP, Belvisi M, Papi A, Kotenko SV, Johnston SL, Edwards MR. EMBO Mol Med 4 1244-1260 (2012)
  61. The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50. Cheng CS, Feldman KE, Lee J, Verma S, Huang DB, Huynh K, Chang M, Ponomarenko JV, Sun SC, Benedict CA, Ghosh G, Hoffmann A. Sci Signal 4 ra11 (2011)
  62. The structure of an Arf-ArfGAP complex reveals a Ca2+ regulatory mechanism. Ismail SA, Vetter IR, Sot B, Wittinghofer A. Cell 141 812-821 (2010)
  63. Extensive cooperation of immune master regulators IRF3 and NFκB in RNA Pol II recruitment and pause release in human innate antiviral transcription. Freaney JE, Kim R, Mandhana R, Horvath CM. Cell Rep 4 959-973 (2013)
  64. Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. Ricour C, Delhaye S, Hato SV, Olenyik TD, Michel B, van Kuppeveld FJ, Gustin KE, Michiels T. J Gen Virol 90 177-186 (2009)
  65. The DEAH-box RNA helicase DHX15 activates NF-κB and MAPK signaling downstream of MAVS during antiviral responses. Mosallanejad K, Sekine Y, Ishikura-Kinoshita S, Kumagai K, Nagano T, Matsuzawa A, Takeda K, Naguro I, Ichijo H. Sci Signal 7 ra40 (2014)
  66. Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Pertel T, Reinhard C, Luban J. Retrovirology 8 49 (2011)
  67. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. Cloutier N, Flamand L. J Biol Chem 285 7208-7221 (2010)
  68. Lactobacilli and bifidobacteria induce differential interferon-β profiles in dendritic cells. Weiss G, Christensen HR, Zeuthen LH, Vogensen FK, Jakobsen M, Frøkiær H. Cytokine 56 520-530 (2011)
  69. Occupancy maps of 208 chromatin-associated proteins in one human cell type. Partridge EC, Chhetri SB, Prokop JW, Ramaker RC, Jansen CS, Goh ST, Mackiewicz M, Newberry KM, Brandsmeier LA, Meadows SK, Messer CL, Hardigan AA, Coppola CJ, Dean EC, Jiang S, Savic D, Mortazavi A, Wold BJ, Myers RM, Mendenhall EM. Nature 583 720-728 (2020)
  70. Porcine reproductive and respiratory syndrome virus non-structural protein 1 suppresses tumor necrosis factor-alpha promoter activation by inhibiting NF-κB and Sp1. Subramaniam S, Kwon B, Beura LK, Kuszynski CA, Pattnaik AK, Osorio FA. Virology 406 270-279 (2010)
  71. Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation. Meng F, Zhou R, Wu S, Zhang Q, Jin Q, Zhou Y, Plouffe SW, Liu S, Song H, Xia Z, Zhao B, Ye S, Feng XH, Guan KL, Zou J, Xu P. Genes Dev 30 1086-1100 (2016)
  72. Arabidopsis thaliana AHL family modulates hypocotyl growth redundantly by interacting with each other via the PPC/DUF296 domain. Zhao J, Favero DS, Peng H, Neff MM. Proc Natl Acad Sci U S A 110 E4688-97 (2013)
  73. Both TLR2 and TRIF contribute to interferon-β production during Listeria infection. Aubry C, Corr SC, Wienerroither S, Goulard C, Jones R, Jamieson AM, Decker T, O'Neill LA, Dussurget O, Cossart P. PLoS One 7 e33299 (2012)
  74. Integration of ChIP-seq and machine learning reveals enhancers and a predictive regulatory sequence vocabulary in melanocytes. Gorkin DU, Lee D, Reed X, Fletez-Brant C, Bessling SL, Loftus SK, Beer MA, Pavan WJ, McCallion AS. Genome Res 22 2290-2301 (2012)
  75. RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide. Carrión M, Juarranz Y, Pérez-García S, Jimeno R, Pablos JL, Gomariz RP, Gutiérrez-Cañas I. Arthritis Rheum 63 1626-1636 (2011)
  76. Structural basis for cyclic Py-Im polyamide allosteric inhibition of nuclear receptor binding. Chenoweth DM, Dervan PB. J Am Chem Soc 132 14521-14529 (2010)
  77. Structural basis of HIV-1 activation by NF-kappaB--a higher-order complex of p50:RelA bound to the HIV-1 LTR. Stroud JC, Oltman A, Han A, Bates DL, Chen L. J Mol Biol 393 98-112 (2009)
  78. Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus. Li Z, Okonski KM, Samuel CE. J Virol 86 3787-3794 (2012)
  79. Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain. Arnold MM, Barro M, Patton JT. J Virol 87 9813-9821 (2013)
  80. Cooperative interactions enable singular olfactory receptor expression in mouse olfactory neurons. Monahan K, Schieren I, Cheung J, Mumbey-Wafula A, Monuki ES, Lomvardas S. Elife 6 e28620 (2017)
  81. Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. Dong X, Feng H, Sun Q, Li H, Wu TT, Sun R, Tibbetts SA, Chen ZJ, Feng P. PLoS Pathog 6 e1001001 (2010)
  82. Positional specificity of different transcription factor classes within enhancers. Grossman SR, Engreitz J, Ray JP, Nguyen TH, Hacohen N, Lander ES. Proc Natl Acad Sci U S A 115 E7222-E7230 (2018)
  83. The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication. Nilsson-Payant BE, Uhl S, Grimont A, Doane AS, Cohen P, Patel RS, Higgins CA, Acklin JA, Bram Y, Chandar V, Blanco-Melo D, Panis M, Lim JK, Elemento O, Schwartz RE, Rosenberg BR, Chandwani R, tenOever BR. J Virol 95 e0125721 (2021)
  84. Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production. Siednienko J, Gajanayake T, Fitzgerald KA, Moynagh P, Miggin SM. J Immunol 186 2514-2522 (2011)
  85. Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Hu J, Sealfon SC, Hayot F, Jayaprakash C, Kumar M, Pendleton AC, Ganee A, Fernandez-Sesma A, Moran TM, Wetmur JG. Nucleic Acids Res 35 5232-5241 (2007)
  86. Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elements. Inoue T, Kohro T, Tanaka T, Kanki Y, Li G, Poh HM, Mimura I, Kobayashi M, Taguchi A, Maejima T, Suehiro J, Sugiyama A, Kaneki K, Aruga H, Dong S, Stevens JF, Yamamoto S, Tsutsumi S, Fujita T, Ruan X, Aburatani H, Nangaku M, Ruan Y, Kodama T, Wada Y. Genome Biol 15 R63 (2014)
  87. Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. DeWitte-Orr SJ, Mehta DR, Collins SE, Suthar MS, Gale M, Mossman KL. J Immunol 183 6545-6553 (2009)
  88. Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control. Kim CC, Nelson CS, Wilson EB, Hou B, DeFranco AL, DeRisi JL. PLoS One 7 e48126 (2012)
  89. DNA-binding landscape of IRF3, IRF5 and IRF7 dimers: implications for dimer-specific gene regulation. Andrilenas KK, Ramlall V, Kurland J, Leung B, Harbaugh AG, Siggers T. Nucleic Acids Res 46 2509-2520 (2018)
  90. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function. Rengachari S, Groiss S, Devos JM, Caron E, Grandvaux N, Panne D. Proc Natl Acad Sci U S A 115 E601-E609 (2018)
  91. A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. Hu J, Nistal-Villán E, Voho A, Ganee A, Kumar M, Ding Y, García-Sastre A, Wetmur JG. J Immunol 185 424-432 (2010)
  92. Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production. Sun Y, Ke H, Han M, Chen N, Fang W, Yoo D. PLoS One 11 e0168314 (2016)
  93. Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. Aresté C, Mutocheluh M, Blackbourn DJ. J Biol Chem 284 23272-23285 (2009)
  94. Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells. Altintas DM, Shukla MS, Goutte-Gattat D, Angelov D, Rouault JP, Dimitrov S, Samarut J. Mol Endocrinol 26 1531-1541 (2012)
  95. Mechanism of origin DNA recognition and assembly of an initiator-helicase complex by SV40 large tumor antigen. Chang YP, Xu M, Machado AC, Yu XJ, Rohs R, Chen XS. Cell Rep 3 1117-1127 (2013)
  96. Sequence determinants of human gene regulatory elements. Sahu B, Hartonen T, Pihlajamaa P, Wei B, Dave K, Zhu F, Kaasinen E, Lidschreiber K, Lidschreiber M, Daub CO, Cramer P, Kivioja T, Taipale J. Nat Genet 54 283-294 (2022)
  97. Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45. Sathish N, Zhu FX, Golub EE, Liang Q, Yuan Y. J Biol Chem 286 746-756 (2011)
  98. Subtle changes in motif positioning cause tissue-specific effects on robustness of an enhancer's activity. Erceg J, Saunders TE, Girardot C, Devos DP, Hufnagel L, Furlong EE. PLoS Genet 10 e1004060 (2014)
  99. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Siednienko J, Halle A, Nagpal K, Golenbock DT, Miggin SM. Eur J Immunol 40 3150-3160 (2010)
  100. The words of the regulatory code are arranged in a variable manner in highly conserved enhancers. Rastegar S, Hess I, Dickmeis T, Nicod JC, Ertzer R, Hadzhiev Y, Thies WG, Scherer G, Strähle U. Dev Biol 318 366-377 (2008)
  101. Construction of a large scale integrated map of macrophage pathogen recognition and effector systems. Raza S, McDerment N, Lacaze PA, Robertson K, Watterson S, Chen Y, Chisholm M, Eleftheriadis G, Monk S, O'Sullivan M, Turnbull A, Roy D, Theocharidis A, Ghazal P, Freeman TC. BMC Syst Biol 4 63 (2010)
  102. Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance. Hundeshagen A, Hecker M, Paap BK, Angerstein C, Kandulski O, Fatum C, Hartmann C, Koczan D, Thiesen HJ, Zettl UK. J Neuroinflammation 9 140 (2012)
  103. Murine gamma herpesvirus 68 hijacks MAVS and IKKβ to abrogate NFκB activation and antiviral cytokine production. Dong X, Feng P. PLoS Pathog 7 e1002336 (2011)
  104. Targeted chemical wedges reveal the role of allosteric DNA modulation in protein-DNA assembly. Moretti R, Donato LJ, Brezinski ML, Stafford RL, Hoff H, Thorson JS, Dervan PB, Ansari AZ. ACS Chem Biol 3 220-229 (2008)
  105. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. Nociari M, Ocheretina O, Murphy M, Falck-Pedersen E. J Virol 83 4081-4091 (2009)
  106. An ancient Pygo-dependent Wnt enhanceosome integrated by Chip/LDB-SSDP. Fiedler M, Graeb M, Mieszczanek J, Rutherford TJ, Johnson CM, Bienz M. Elife 4 (2015)
  107. Bipartite Nuclear Localization Signal Controls Nuclear Import and DNA-Binding Activity of IFN Regulatory Factor 3. Zhu M, Fang T, Li S, Meng K, Guo D. J Immunol 195 289-297 (2015)
  108. Cell-cell fusion induced by measles virus amplifies the type I interferon response. Herschke F, Plumet S, Duhen T, Azocar O, Druelle J, Laine D, Wild TF, Rabourdin-Combe C, Gerlier D, Valentin H. J Virol 81 12859-12871 (2007)
  109. Differential modification of interferon regulatory factor 3 following virus particle entry. Noyce RS, Collins SE, Mossman KL. J Virol 83 4013-4022 (2009)
  110. Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression. Wang L, Toomey NL, Diaz LA, Walker G, Ramos JC, Barber GN, Ning S. J Virol 85 8328-8337 (2011)
  111. Protein kinase PKR catalytic activity is required for the PKR-dependent activation of mitogen-activated protein kinases and amplification of interferon beta induction following virus infection. Taghavi N, Samuel CE. Virology 427 208-216 (2012)
  112. Inhibition of IRF5 hyperactivation protects from lupus onset and severity. Song S, De S, Nelson V, Chopra S, LaPan M, Kampta K, Sun S, He M, Thompson CD, Li D, Shih T, Tan N, Al-Abed Y, Capitle E, Aranow C, Mackay M, Clapp WL, Barnes BJ. J Clin Invest 130 6700-6717 (2020)
  113. Interferon response and viral evasion by members of the family rhabdoviridae. Faul EJ, Lyles DS, Schnell MJ. Viruses 1 832-851 (2009)
  114. Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood. Hecker M, Hartmann C, Kandulski O, Paap BK, Koczan D, Thiesen HJ, Zettl UK. Mol Neurobiol 48 737-756 (2013)
  115. Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression. Farlik M, Rapp B, Marie I, Levy DE, Jamieson AM, Decker T. Mol Cell Biol 32 1032-1043 (2012)
  116. Intronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcription. Camp JG, Jazwa AL, Trent CM, Rawls JF. PLoS Genet 8 e1002585 (2012)
  117. Negative regulation of interferon-β gene expression during acute and persistent virus infections. Ye J, Maniatis T. PLoS One 6 e20681 (2011)
  118. Nuclear factor κB subunits RelB and cRel negatively regulate Toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1. Siednienko J, Maratha A, Yang S, Mitkiewicz M, Miggin SM, Moynagh PN. J Biol Chem 286 44750-44763 (2011)
  119. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression. Chen Y, Wright J, Meng X, Leppard KN. Mol Cell Biol 35 1660-1672 (2015)
  120. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15. Ahmed S, Maratha A, Butt AQ, Shevlin E, Miggin SM. J Immunol 190 2217-2228 (2013)
  121. Type I interferon response impairs differentiation potential of pluripotent stem cells. Eggenberger J, Blanco-Melo D, Panis M, Brennand KJ, tenOever BR. Proc Natl Acad Sci U S A 116 1384-1393 (2019)
  122. Dynamic cross talk model of the epithelial innate immune response to double-stranded RNA stimulation: coordinated dynamics emerging from cell-level noise. Bertolusso R, Tian B, Zhao Y, Vergara L, Sabree A, Iwanaszko M, Lipniacki T, Brasier AR, Kimmel M. PLoS One 9 e93396 (2014)
  123. Exploiting genetic variation to uncover rules of transcription factor binding and chromatin accessibility. Behera V, Evans P, Face CJ, Hamagami N, Sankaranarayanan L, Keller CA, Giardine B, Tan K, Hardison RC, Shi J, Blobel GA. Nat Commun 9 782 (2018)
  124. Massively parallel reporter assays in cultured mammalian cells. Melnikov A, Zhang X, Rogov P, Wang L, Mikkelsen TS. J Vis Exp (2014)
  125. Single-molecule dynamics and genome-wide transcriptomics reveal that NF-kB (p65)-DNA binding times can be decoupled from transcriptional activation. Callegari A, Sieben C, Benke A, Suter DM, Fierz B, Mazza D, Manley S. PLoS Genet 15 e1007891 (2019)
  126. Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells. Lam E, Falck-Pedersen E. J Virol 88 14426-14439 (2014)
  127. Letter A rationale for the enhanceosome and other evolutionarily constrained enhancers. Papatsenko D, Levine M. Curr Biol 17 R955-7 (2007)
  128. Assembly of human C-terminal binding protein (CtBP) into tetramers. Bellesis AG, Jecrois AM, Hayes JA, Schiffer CA, Royer WE. J Biol Chem 293 9101-9112 (2018)
  129. Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways. Kasper LH, Thomas MC, Zambetti GP, Brindle PK. Cell Cycle 10 212-221 (2011)
  130. Immunology. Cooperative transcription factor complexes in control. Martinez GJ, Rao A. Science 338 891-892 (2012)
  131. Dissecting the sharp response of a canonical developmental enhancer reveals multiple sources of cooperativity. Park J, Estrada J, Johnson G, Vincent BJ, Ricci-Tam C, Bragdon MD, Shulgina Y, Cha A, Wunderlich Z, Gunawardena J, DePace AH. Elife 8 e41266 (2019)
  132. Interactions between pluripotency factors specify cis-regulation in embryonic stem cells. Fiore C, Cohen BA. Genome Res 26 778-786 (2016)
  133. Iterative Modeling Reveals Evidence of Sequential Transcriptional Control Mechanisms. Cheng CS, Behar MS, Suryawanshi GW, Feldman KE, Spreafico R, Hoffmann A. Cell Syst 4 330-343.e5 (2017)
  134. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells. Sutton SK, Koach J, Tan O, Liu B, Carter DR, Wilmott JS, Yosufi B, Haydu LE, Mann GJ, Thompson JF, Long GV, Liu T, McArthur G, Zhang XD, Scolyer RA, Cheung BB, Marshall GM. Oncotarget 5 10127-10139 (2014)
  135. The matrix protein of rabies virus binds to RelAp43 to modulate NF-κB-dependent gene expression related to innate immunity. Ben Khalifa Y, Luco S, Besson B, Sonthonnax F, Archambaud M, Grimes JM, Larrous F, Bourhy H. Sci Rep 6 39420 (2016)
  136. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection. Yim HC, Li JC, Lau JS, Lau AS. AIDS 23 1473-1484 (2009)
  137. Assembling the human IFN-beta enhanceosome in solution. Dragan AI, Carrillo R, Gerasimova TI, Privalov PL. J Mol Biol 384 335-348 (2008)
  138. Molecular mechanism underlying the regulatory specificity of a Drosophila homeodomain protein that specifies myoblast identity. Busser BW, Shokri L, Jaeger SA, Gisselbrecht SS, Singhania A, Berger MF, Zhou B, Bulyk ML, Michelson AM. Development 139 1164-1174 (2012)
  139. Uncoupling evolutionary changes in DNA sequence, transcription factor occupancy and enhancer activity. Khoueiry P, Girardot C, Ciglar L, Peng PC, Gustafson EH, Sinha S, Furlong EE. Elife 6 e28440 (2017)
  140. Identification of a novel in vivo virus-targeted phosphorylation site in interferon regulatory factor-3 (IRF3). Bergstroem B, Johnsen IB, Nguyen TT, Hagen L, Slupphaug G, Thommesen L, Anthonsen MW. J Biol Chem 285 24904-24914 (2010)
  141. MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway. Xu H, Xu SJ, Xie SJ, Zhang Y, Yang JH, Zhang WQ, Zheng MN, Zhou H, Qu LH. Elife 8 e41159 (2019)
  142. Molecular Insight Into the IRE1α-Mediated Type I Interferon Response Induced by Proteasome Impairment in Myeloid Cells of the Brain. Studencka-Turski M, Çetin G, Junker H, Ebstein F, Krüger E. Front Immunol 10 2900 (2019)
  143. Combined genome-wide expression profiling and targeted RNA interference in primary mouse macrophages reveals perturbation of transcriptional networks associated with interferon signalling. Lacaze P, Raza S, Sing G, Page D, Forster T, Storm P, Craigon M, Awad T, Ghazal P, Freeman TC. BMC Genomics 10 372 (2009)
  144. Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway. Liang X, Huang Y, Pan X, Hao Y, Chen X, Jiang H, Li J, Zhou B, Yang Z. J Pharm Anal 10 130-146 (2020)
  145. Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus. Schmid S, Sachs D, tenOever BR. J Biol Chem 289 299-311 (2014)
  146. Quantitatively predictable control of Drosophila transcriptional enhancers in vivo with engineered transcription factors. Crocker J, Ilsley GR, Stern DL. Nat Genet 48 292-298 (2016)
  147. Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells. Yin H, Zhou H, Kang Y, Zhang X, Duan X, Alnabhan R, Liang S, Scott DA, Lamont RJ, Shang J, Wang H. Biochim Biophys Acta 1860 588-598 (2016)
  148. The most deeply conserved noncoding sequences in plants serve similar functions to those in vertebrates despite large differences in evolutionary rates. Burgess D, Freeling M. Plant Cell 26 946-961 (2014)
  149. β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling. Zhou BX, Li J, Liang XL, Pan XP, Hao YB, Xie PF, Jiang HM, Yang ZF, Zhong NS. Acta Pharmacol Sin 41 1178-1196 (2020)
  150. A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions. Shiina M, Hamada K, Inoue-Bungo T, Shimamura M, Uchiyama A, Baba S, Sato K, Yamamoto M, Ogata K. J Mol Biol 427 1655-1669 (2015)
  151. Cut, copy, move, delete: The study of human interferon genes reveal multiple mechanisms underlying their evolution in amniotes. Krause CD, Pestka S. Cytokine 76 480-495 (2015)
  152. Finding evolutionarily conserved cis-regulatory modules with a universal set of motifs. Wilczynski B, Dojer N, Patelak M, Tiuryn J. BMC Bioinformatics 10 82 (2009)
  153. NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells. Bao M, Wang Y, Liu Y, Shi P, Lu H, Sha W, Weng L, Hanabuchi S, Qin J, Plumas J, Chaperot L, Zhang Z, Liu YJ. J Exp Med 213 2383-2398 (2016)
  154. The murine cytomegalovirus M35 protein antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-κB mediated transcription. Chan B, Gonçalves Magalhães V, Lemmermann NAW, Juranić Lisnić V, Stempel M, Bussey KA, Reimer E, Podlech J, Lienenklaus S, Reddehase MJ, Jonjić S, Brinkmann MM. PLoS Pathog 13 e1006382 (2017)
  155. Using chirality to probe the conformational dynamics and assembly of intrinsically disordered amyloid proteins. Raskatov JA, Teplow DB. Sci Rep 7 12433 (2017)
  156. Complex Regulation Pattern of IRF3 Activation Revealed by a Novel Dimerization Reporter System. Wang Z, Ji J, Peng D, Ma F, Cheng G, Qin FX. J Immunol 196 4322-4330 (2016)
  157. Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression. Génin P, Lin R, Hiscott J, Civas A. PLoS One 7 e38336 (2012)
  158. Cooperative DNA Recognition Modulated by an Interplay between Protein-Protein Interactions and DNA-Mediated Allostery. Merino F, Bouvier B, Cojocaru V. PLoS Comput Biol 11 e1004287 (2015)
  159. Regulation of cooperative function of the Il12b enhancer and promoter by the interferon regulatory factors 3 and 5. Koshiba R, Yanai H, Matsuda A, Goto A, Nakajima A, Negishi H, Nishio J, Smale ST, Taniguchi T. Biochem Biophys Res Commun 430 95-100 (2013)
  160. Specific enhancer selection by IRF3, IRF5 and IRF9 is determined by ISRE half-sites, 5' and 3' flanking bases, collaborating transcription factors and the chromatin environment in a combinatorial fashion. Csumita M, Csermely A, Horvath A, Nagy G, Monori F, Göczi L, Orbea HA, Reith W, Széles L. Nucleic Acids Res 48 589-604 (2020)
  161. The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor. Hew K, Dahlroth SL, Venkatachalam R, Nasertorabi F, Lim BT, Cornvik T, Nordlund P. Nucleic Acids Res 41 4295-4306 (2013)
  162. Glatiramer acetate treatment negatively regulates type I interferon signaling. Molnarfi N, Prod'homme T, Schulze-Topphoff U, Spencer CM, Weber MS, Patarroyo JC, Lalive PH, Zamvil SS. Neurol Neuroimmunol Neuroinflamm 2 e179 (2015)
  163. Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis. De Luna N, Suárez-Calvet X, Lleixà C, Diaz-Manera J, Olivé M, Illa I, Gallardo E. Sci Rep 7 8595 (2017)
  164. Upregulation of Interferon Regulatory Factor 6 Promotes Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats. Lin Y, Xu D, Li X, Liu C, Liu X, Huang S, Huang Y, Liu X. Cell Mol Neurobiol 36 27-36 (2016)
  165. CCAT: Combinatorial Code Analysis Tool for transcriptional regulation. Jiang P, Singh M. Nucleic Acids Res 42 2833-2847 (2014)
  166. Discover context-specific combinatorial transcription factor interactions by integrating diverse ChIP-Seq data sets. Teng L, He B, Gao P, Gao L, Tan K. Nucleic Acids Res 42 e24 (2014)
  167. Human Cytokinome Analysis for Interferon Response. Al-Yahya S, Mahmoud L, Al-Zoghaibi F, Al-Tuhami A, Amer H, Almajhdi FN, Polyak SJ, Khabar KS. J Virol 89 7108-7119 (2015)
  168. IRF2 is a master regulator of human keratinocyte stem cell fate. Mercado N, Schutzius G, Kolter C, Estoppey D, Bergling S, Roma G, Gubser Keller C, Nigsch F, Salathe A, Terranova R, Reece-Hoyes J, Alford J, Russ C, Knehr J, Hoepfner D, Aebi A, Ruffner H, Beck TC, Jagannathan S, Olson CM, Sheppard HE, Elsarrag SZ, Bouwmeester T, Frederiksen M, Lohmann F, Lin CY, Kirkland S. Nat Commun 10 4676 (2019)
  169. Mapping polyamide-DNA interactions in human cells reveals a new design strategy for effective targeting of genomic sites. Erwin GS, Bhimsaria D, Eguchi A, Ansari AZ. Angew Chem Int Ed Engl 53 10124-10128 (2014)
  170. Miniseries: Illustrating the machinery of life: Eukaryotic cell panorama. Goodsell DS. Biochem Mol Biol Educ 39 91-101 (2011)
  171. NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3. Wuerth JD, Habjan M, Wulle J, Superti-Furga G, Pichlmair A, Weber F. J Virol 92 e01202-18 (2018)
  172. Structural insights into p300 regulation and acetylation-dependent genome organisation. Ibrahim Z, Wang T, Destaing O, Salvi N, Hoghoughi N, Chabert C, Rusu A, Gao J, Feletto L, Reynoird N, Schalch T, Zhao Y, Blackledge M, Khochbin S, Panne D. Nat Commun 13 7759 (2022)
  173. The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas. Bhattacharya B, Xiao S, Chatterjee S, Urbanowski M, Ordonez A, Ihms EA, Agrahari G, Lun S, Berland R, Pichugin A, Gao Y, Connor J, Ivanov AR, Yan BS, Kobzik L, Koo BB, Jain S, Bishai W, Kramnik I. J Clin Invest 131 130319 (2021)
  174. Binding of high mobility group A proteins to the mammalian genome occurs as a function of AT-content. Colombo DF, Burger L, Baubec T, Schübeler D. PLoS Genet 13 e1007102 (2017)
  175. Hitting the bull's eye: targeting HMGA1 in cancer stem cells. Yanagisawa BL, Resar LM. Expert Rev Anticancer Ther 14 23-30 (2014)
  176. Stability and DNA-binding ability of the bZIP dimers formed by the ATF-2 and c-Jun transcription factors. Carrillo RJ, Dragan AI, Privalov PL. J Mol Biol 396 431-440 (2010)
  177. The IKK Kinases: Operators of Antiviral Signaling. Pham AM, TenOever BR. Viruses 2 55-72 (2010)
  178. The transcription factor NFAT5 limits infection-induced type I interferon responses. Huerga Encabo H, Traveset L, Argilaguet J, Angulo A, Nistal-Villán E, Jaiswal R, Escalante CR, Gekas C, Meyerhans A, Aramburu J, López-Rodríguez C. J Exp Med 217 e20190449 (2020)
  179. Transcription factors interact with RNA to regulate genes. Oksuz O, Henninger JE, Warneford-Thomson R, Zheng MM, Erb H, Vancura A, Overholt KJ, Hawken SW, Banani SF, Lauman R, Reich LN, Robertson AL, Hannett NM, Lee TI, Zon LI, Bonasio R, Young RA. Mol Cell 83 2449-2463.e13 (2023)
  180. Comparative Analysis of Immune Cells Reveals a Conserved Regulatory Lexicon. Donnard E, Vangala P, Afik S, McCauley S, Nowosielska A, Kucukural A, Tabak B, Zhu X, Diehl W, McDonel P, Yosef N, Luban J, Garber M. Cell Syst 6 381-394.e7 (2018)
  181. Global dynamics of stage-specific transcription factor binding during thymocyte development. Hosoya T, D'Oliveira Albanus R, Hensley J, Myers G, Kyono Y, Kitzman J, Parker SCJ, Engel JD. Sci Rep 8 5605 (2018)
  182. The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB. Dam S, Kracht M, Pleschka S, Schmitz ML. J Virol 90 7980-7990 (2016)
  183. Allostery through DNA drives phenotype switching. Rosenblum G, Elad N, Rozenberg H, Wiggers F, Jungwirth J, Hofmann H. Nat Commun 12 2967 (2021)
  184. Beyond the enhanceosome: cluster of novel κB sites downstream of the human IFN-β gene is essential for lipopolysaccharide-induced gene activation. Goh FG, Thomson SJ, Krausgruber T, Lanfrancotti A, Copley RR, Udalova IA. Blood 116 5580-5588 (2010)
  185. Identification of co-occurring transcription factor binding sites from DNA sequence using clustered position weight matrices. Oh YM, Kim JK, Choi S, Yoo JY. Nucleic Acids Res 40 e38 (2012)
  186. A role for insulator elements in the regulation of gene expression response to hypoxia. Tiana M, Villar D, Pérez-Guijarro E, Gómez-Maldonado L, Moltó E, Fernández-Miñán A, Gómez-Skarmeta JL, Montoliu L, del Peso L. Nucleic Acids Res 40 1916-1927 (2012)
  187. Both IRF3 and especially IRF7 play a key role to orchestrate an effective cerebral inflammatory response in a mouse model of herpes simplex virus encephalitis. Canivet C, Rhéaume C, Lebel M, Piret J, Gosselin J, Boivin G. J Neurovirol 24 761-768 (2018)
  188. Differential gene expression downstream of Toll-like receptors (TLRs): role of c-Src and activating transcription factor 3 (ATF3). Nguyen TT, Johnsen IB, Knetter CF, Drabløs F, Fitzgerald KA, Lien E, Anthonsen MW. J Biol Chem 285 17011-17019 (2010)
  189. Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites. Madison BJ, Clark KA, Bhachech N, Hollenhorst PC, Graves BJ, Currie SL. J Biol Chem 293 18624-18635 (2018)
  190. IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages. Moore TC, Al-Salleeh FM, Brown DM, Petro TM. Virology 418 40-48 (2011)
  191. PRAS40 promotes NF-κB transcriptional activity through association with p65. Zhu G, Qi Q, Havel JJ, Li Z, Du Y, Zhang X, Fu H. Oncogenesis 6 e381 (2017)
  192. Structure-function dissection of Myxococcus xanthus CarD N-terminal domain, a defining member of the CarD_CdnL_TRCF family of RNA polymerase interacting proteins. Bernal-Bernal D, Gallego-García A, García-Martínez G, García-Heras F, Jiménez MA, Padmanabhan S, Elías-Arnanz M. PLoS One 10 e0121322 (2015)
  193. AP-1 subunits converge promiscuously at enhancers to potentiate transcription. Seo J, Koçak DD, Bartelt LC, Williams CA, Barrera A, Gersbach CA, Reddy TE. Genome Res 31 538-550 (2021)
  194. Causal Gene Regulatory Network Modeling and Genomics: Second-Generation Challenges. Rothenberg EV. J Comput Biol 26 703-718 (2019)
  195. Power-laws in interferon-B mRNA distribution in virus-infected dendritic cells. Hu J, Iyer-Biswas S, Sealfon SC, Wetmur J, Jayaprakash C, Hayot F. Biophys J 97 1984-1989 (2009)
  196. Role of sequence encoded κB DNA geometry in gene regulation by Dorsal. Mrinal N, Tomar A, Nagaraju J. Nucleic Acids Res 39 9574-9591 (2011)
  197. "Stripe" transcription factors provide accessibility to co-binding partners in mammalian genomes. Zhao Y, Vartak SV, Conte A, Wang X, Garcia DA, Stevens E, Kyoung Jung S, Kieffer-Kwon KR, Vian L, Stodola T, Moris F, Chopp L, Preite S, Schwartzberg PL, Kulinski JM, Olivera A, Harly C, Bhandoola A, Heuston EF, Bodine DM, Urrutia R, Upadhyaya A, Weirauch MT, Hager G, Casellas R. Mol Cell 82 3398-3411.e11 (2022)
  198. Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor. Hu H, Dong J, Liang D, Gao Z, Bai L, Sun R, Hu H, Zhang H, Dong Y, Lan K. J Virol 90 1158-1168 (2016)
  199. Lysine residues of interferon regulatory factor 7 affect the replication and transcription activator-mediated lytic replication of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Zhang T, Wang Y, Zhang L, Liu B, Xie J, Wood C, Wang J. J Gen Virol 92 181-187 (2011)
  200. Shedding (blue) light on algal gene expression. Losi A, Gärtner W. Proc Natl Acad Sci U S A 105 7-8 (2008)
  201. Structural determinants of the IRF4/DNA homodimeric complex. Sundararaj S, Seneviratne S, Williams SJ, Enders A, Casarotto MG. Nucleic Acids Res 49 2255-2265 (2021)
  202. Rainbow Enhancers Regulate Restrictive Transcription in Teleost Green, Red, and Blue Cones. Fang W, Guo C, Wei X. J Neurosci 37 2834-2848 (2017)
  203. Capturing cooperative interactions with the PSI-MI format. Van Roey K, Orchard S, Kerrien S, Dumousseau M, Ricard-Blum S, Hermjakob H, Gibson TJ. Database (Oxford) 2013 bat066 (2013)
  204. Characterization of the Stoichiometry of HMGA1/DNA Complexes. Watanabe M, Ni S, Lindenberger AL, Cho J, Tinch SL, Kennedy MA. Open Biochem J 7 73-81 (2013)
  205. Cooperative DNA binding by proteins through DNA shape complementarity. Hancock SP, Cascio D, Johnson RC. Nucleic Acids Res 47 8874-8887 (2019)
  206. Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs. Gringhuis SI, Kaptein TM, Remmerswaal EBM, Drewniak A, Wevers BA, Theelen B, D'Haens GRAM, Boekhout T, Geijtenbeek TBH. Nat Immunol 23 1735-1748 (2022)
  207. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. Takaki H, Honda K, Atarashi K, Kobayashi F, Ebihara T, Oshiumi H, Matsumoto M, Shingai M, Seya T. Mol Immunol 57 100-110 (2014)
  208. Zebrafish NDRG1a Negatively Regulates IFN Induction by Promoting the Degradation of IRF7. Lu LF, Li S, Wang ZX, Liu SB, Chen DD, Zhang YA. J Immunol 202 119-130 (2019)
  209. Model of a DNA-protein complex of the architectural monomeric protein MC1 from Euryarchaea. Paquet F, Delalande O, Goffinont S, Culard F, Loth K, Asseline U, Castaing B, Landon C. PLoS One 9 e88809 (2014)
  210. Modular discovery of monomeric and dimeric transcription factor binding motifs for large data sets. Toivonen J, Kivioja T, Jolma A, Yin Y, Taipale J, Ukkonen E. Nucleic Acids Res 46 e44 (2018)
  211. Recruitment and delivery of the fission yeast Rst2 transcription factor via a local genome structure counteracts repression by Tup1-family corepressors. Asada R, Umeda M, Adachi A, Senmatsu S, Abe T, Iwasaki H, Ohta K, Hoffman CS, Hirota K. Nucleic Acids Res 45 9361-9371 (2017)
  212. Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability. Hassan F, Ni S, Arnett TC, McKell MC, Kennedy MA. Mol Ther Oncolytics 8 52-61 (2018)
  213. Functional genetic variants of the IFN-λ3 (IL28B) gene and transcription factor interactions on its promoter. Roy S, Guha Roy D, Bhushan A, Bharatiya S, Chinnaswamy S. Cytokine 142 155491 (2021)
  214. Porcine bocavirus NP1 protein suppresses type I IFN production by interfering with IRF3 DNA-binding activity. Zhang R, Fang L, Wu W, Zhao F, Song T, Xie L, Li Y, Chen H, Xiao S. Virus Genes 52 797-805 (2016)
  215. Promoter Binding and Nuclear Retention Features of Zebrafish IRF Family Members in IFN Response. An LL, Zhao X, Gong XY, Li YL, Qu ZL, Sun HY, Guo WH, Dan C, Gui JF, Zhang YB. Front Immunol 13 861262 (2022)
  216. Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation. Wang BX, Brown EG, Fish EN. Virology 508 170-179 (2017)
  217. The flexibility of a homeodomain transcription factor heterodimer and its allosteric regulation by DNA binding. Mathiasen L, Valentini E, Boivin S, Cattaneo A, Blasi F, Svergun DI, Bruckmann C. FEBS J 283 3134-3154 (2016)
  218. News Three-dimensional intricacies in protein-DNA recognition and transcriptional control. Harrison SC. Nat Struct Mol Biol 14 1118-1119 (2007)
  219. Adaptations of Interferon Regulatory Factor 3 with Transition from Terrestrial to Aquatic Life. Angeletti M, Hsu WN, Majo N, Moriyama H, Moriyama EN, Zhang L. Sci Rep 10 4508 (2020)
  220. Antiviral interferon-beta signaling induced by designed transcription activator-like effectors (TALE). Renner I, Funk N, Geissler R, Friedrich S, Penzel A, Behrens SE. PLoS One 9 e114288 (2014)
  221. GABPα Binding to Overlapping ETS and CRE DNA Motifs Is Enhanced by CREB1: Custom DNA Microarrays. He X, Syed KS, Tillo D, Mann I, Weirauch MT, Vinson C. G3 (Bethesda) 5 1909-1918 (2015)
  222. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression. Poirson J, Suarez IP, Straub ML, Cousido-Siah A, Peixoto P, Hervouet E, Foster A, Mitschler A, Mukobo N, Chebaro Y, Garcin D, Recberlik S, Gaiddon C, Altschuh D, Nominé Y, Podjarny A, Trave G, Masson M. J Virol 96 e0187521 (2022)
  223. NF-κB Rel subunit exchange on a physiological timescale. Biancalana M, Natan E, Lenardo MJ, Fersht AR. Protein Sci 30 1818-1832 (2021)
  224. Noise propagation through extracellular signaling leads to fluctuations in gene expression. Tabbaa OP, Nudelman G, Sealfon SC, Hayot F, Jayaprakash C. BMC Syst Biol 7 94 (2013)
  225. Quantitative analysis of transcription factor binding and expression using calling cards reporter arrays. Liu J, Shively CA, Mitra RD. Nucleic Acids Res 48 e50 (2020)
  226. The bacterial iron sensor IdeR recognizes its DNA targets by indirect readout. Marcos-Torres FJ, Maurer D, Juniar L, Griese JJ. Nucleic Acids Res 49 10120-10135 (2021)
  227. The evolution of the macrophage-specific enhancer (Fms intronic regulatory element) within the CSF1R locus of vertebrates. Hume DA, Wollscheid-Lengeling E, Rojo R, Pridans C. Sci Rep 7 17115 (2017)
  228. Wnt target enhancer regulation by a CDX/TCF transcription factor collective and a novel DNA motif. Ramakrishnan AB, Chen L, Burby PE, Cadigan KM. Nucleic Acids Res 49 8625-8641 (2021)
  229. Detection and comparison of protein-DNA interactions using DNA-BIND plate and horseradish peroxidase-based colorimetric assay. Liu B, Qin Y, Wang J, Wang Y. Anal Biochem 412 111-113 (2011)
  230. Exposing the secrets of sex determination. Rohs R, Machado AC, Yang L. Nat Struct Mol Biol 22 437-438 (2015)
  231. Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes TPL2-Mediated Activation of the IRF3/IFN-β Signaling Pathway to Facilitate the Virus Replication. Hao J, Shen C, Wei N, Yan M, Zhang X, Xu G, Zhang D, Hou J, Cao W, Jin Y, Zhang K, Zheng H, Liu X. Front Immunol 11 580334 (2020)
  232. Functional Conservation of a Developmental Switch in Mammals since the Jurassic Age. Mookerjee-Basu J, Hua X, Ge L, Nicolas E, Li Q, Czyzewicz P, Zhongping D, Peri S, FuxmanBass JI, Walhout AJM, Kappes DJ. Mol Biol Evol 36 39-53 (2019)
  233. Global properties of regulatory sequences are predicted by transcription factor recognition mechanisms. Patel ZM, Hughes TR. Genome Biol 22 285 (2021)
  234. Identification and Characterization of Cis-Regulatory Elements for Photoreceptor-Type-Specific Transcription in ZebraFish. Fang W, Wen Y, Wei X. Methods Mol Biol 2092 123-145 (2020)
  235. A genetic variant controls interferon-β gene expression in human myeloid cells by preventing C/EBP-β binding on a conserved enhancer. Assouvie A, Rotival M, Hamroune J, Busso D, Romeo PH, Quintana-Murci L, Rousselet G. PLoS Genet 16 e1009090 (2020)
  236. A shared cis-regulatory module activates transcription in the suspensor of plant embryos. Henry KF, Bui AQ, Kawashima T, Goldberg RB. Proc Natl Acad Sci U S A 115 E5824-E5833 (2018)
  237. FastBill: An Improved Tool for Prediction of Cis-Regulatory Modules. Wilczynski B, Tiuryn J. J Comput Biol 24 193-199 (2017)
  238. Handling Permutation in Sequence Comparison: Genome-Wide Enhancer Prediction in Vertebrates by a Novel Non-Linear Alignment Scoring Principle. Dolle D, Mateo JL, Eichenlaub MP, Sinn R, Reinhardt R, Höckendorf B, Inoue D, Centanin L, Ettwiller L, Wittbrodt J. PLoS One 10 e0141487 (2015)
  239. Inducible cAMP early repressor (ICER) is a novel regulator of RIG-I mediated IFN-β production. Johnsen IB, Bergstroem B, Stiberg KA, Thommesen L, Anthonsen MW. Cell Signal 25 1804-1812 (2013)
  240. MODER2: first-order Markov modeling and discovery of monomeric and dimeric binding motifs. Toivonen J, Das PK, Taipale J, Ukkonen E. Bioinformatics 36 2690-2696 (2020)
  241. Negative regulation of interferon regulatory factor 6 (IRF6) in interferon and NF-κB signalling pathways of common carp (Cyprinus carpio L.). Liang Y, Liu R, Zhang J, Chen Y, Shan S, Zhu Y, Yang G, Li H. BMC Vet Res 18 433 (2022)
  242. PLAAT1 inhibits type I interferon response via degradation of IRF3 and IRF7 in Zebrafish. Zhao X, Huang W, Shi Y, Guo J, Xiao H, Ji N, Feng J, Dang H, Zou J. Front Immunol 13 979919 (2022)
  243. Porcine reproductive and respiratory syndrome virus inhibition of interferon-β transcription by IRF3-independent mechanisms in MARC-145 cells in early infection. Hu H, Zhang X, Zhang H, Wen G, Zhang Q, Li X, Fang W. Vet Immunol Immunopathol 156 135-140 (2013)
  244. Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor. Le-Trilling VTK, Banchenko S, Paydar D, Leipe PM, Binting L, Lauer S, Graziadei A, Klingen R, Gotthold C, Bürger J, Bracht T, Sitek B, Jan Lebbink R, Malyshkina A, Mielke T, Rappsilber J, Spahn CM, Voigt S, Trilling M, Schwefel D. EMBO J 42 e112351 (2023)
  245. ToxR activates the Vibrio cholerae virulence genes by tethering DNA to the membrane through versatile binding to multiple sites. Canals A, Pieretti S, Muriel-Masanes M, El Yaman N, Plecha SC, Thomson JJ, Fàbrega-Ferrer M, Pérez-Luque R, Krukonis ES, Coll M. Proc Natl Acad Sci U S A 120 e2304378120 (2023)
  246. Transcriptional kinetic synergy: A complex landscape revealed by integrating modeling and synthetic biology. Martinez-Corral R, Park M, Biette KM, Friedrich D, Scholes C, Khalil AS, Gunawardena J, DePace AH. Cell Syst 14 324-339.e7 (2023)
  247. Two Interferon-Stimulated Response Elements Cooperatively Regulate Interferon-Stimulated Gene Expression in West Nile Virus-Infected IFNAR-/- Mouse Embryo Fibroblasts. Cui D, Espínola EE, Arora K, Brinton MA. J Virol 95 e0104021 (2021)
  248. Veritas per structuram. Harrison SC. Annu Rev Biochem 84 37-60 (2015)
  249. A new computational method to predict transcriptional activity of a DNA sequence from diverse datasets of massively parallel reporter assays. Liu Y, Irie T, Yada T, Suzuki Y. Nucleic Acids Res 45 e124 (2017)
  250. Affinity-optimizing enhancer variants disrupt development. Lim F, Solvason JJ, Ryan GE, Le SH, Jindal GA, Steffen P, Jandu SK, Farley EK. Nature (2024)
  251. Antagonism between viral infection and innate immunity at the single-cell level. Grabowski F, Kochańczyk M, Korwek Z, Czerkies M, Prus W, Lipniacki T. PLoS Pathog 19 e1011597 (2023)
  252. Co-infection of porcine deltacoronavirus and porcine epidemic diarrhea virus induces early TRAF6-mediated NF-κB and IRF7 signaling pathways through TLRs. Saeng-Chuto K, Madapong A, Kaeoket K, Piñeyro PE, Tantituvanont A, Nilubol D. Sci Rep 12 19443 (2022)
  253. Control of enhancer and promoter activation in the type I interferon response by the histone demethylase Kdm4d/JMJD2d. Chandwani R, Fang TC, Dewell S, Tarakhovsky A. Front Immunol 14 1146699 (2023)
  254. Enhanceosome transcription factors preferentially dimerize with high mobility group proteins. Jankowski A, Obara P, Mathur U, Tiuryn J. BMC Syst Biol 10 14 (2016)
  255. IFN regulatory factor 3 of golden pompano and its NLS domain are involved in antibacterial innate immunity and regulate the expression of type I interferon (IFNa3). Sun Y, Cao Z, Zhang P, Wei C, Li J, Wu Y, Zhou Y. Front Immunol 14 1128196 (2023)
  256. Identification of an IRF-1 splicing transcript in APL cells sharing similar transactivation activity of the full length one. Lou Y, Xia D, Yu M, Tong J, Jin J. Gene 605 108-113 (2017)
  257. Inferring condition-specific targets of human TF-TF complexes using ChIP-seq data. Yang CC, Chen MH, Lin SY, Andrews EH, Cheng C, Liu CC, Chen JJ. BMC Genomics 18 61 (2017)
  258. Molecular dynamics simulations show altered secondary structure of clawless in binary complex with DNA providing insights into aristaless-clawless-DNA ternary complex formation. Kachhap S, Priyadarshini P, Singh B. J Biomol Struct Dyn 35 1153-1167 (2017)
  259. PRKX down-regulates TAK1/IRF7 signaling in the antiviral innate immunity of black carp Mylopharyngodon piceus. Yang X, Ai Y, Chen L, Wang C, Liu J, Zhang J, Li J, Wu H, Xiao J, Chang M, Feng H. Front Immunol 13 999219 (2022)
  260. Structures of NF-κB p52 homodimer-DNA complexes rationalize binding mechanisms and transcription activation. Pan W, Meshcheryakov VA, Li T, Wang Y, Ghosh G, Wang VY. Elife 12 e86258 (2023)
  261. Tenuous transcriptional threshold of human sex determination. II. SRY exploits water-mediated clamp at the edge of ambiguity. Racca JD, Chatterjee D, Chen YS, Rai RK, Yang Y, Georgiadis MM, Haas E, Weiss MA. Front Endocrinol (Lausanne) 13 1029177 (2022)
  262. The Cytomegalovirus M35 Protein Directly Binds to the Interferon-β Enhancer and Modulates Transcription of Ifnb1 and Other IRF3-Driven Genes. Schwanke H, Gonçalves Magalhães V, Schmelz S, Wyler E, Hennig T, Günther T, Grundhoff A, Dölken L, Landthaler M, van Ham M, Jänsch L, Büssow K, van den Heuvel J, Blankenfeldt W, Friedel CC, Erhard F, Brinkmann MM. J Virol 97 e0040023 (2023)
  263. The Non-continuum Nature of Eukaryotic Transcriptional Regulation. Poon GMK. Adv Exp Med Biol 1371 11-32 (2022)
  264. Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism. Pilna H, Hajkova V, Knitlova J, Liskova J, Elsterova J, Melkova Z. Viruses 13 1986 (2021)
  265. [Enhancer activity of DNA fragments from FXYD5-COX7A region of human chromosome 19]. Sorotokina AN, Chernov IP, Stukacheva EA, Nikolaev LG, Sverdlov ED. Bioorg Khim 37 244-252 (2011)